The Bill Is Coming Due For Democrats’ Medicare Overhaul

John Czwartacki, a co-founder of Public Policy Solutions who previously advised at the Office of Management and Budget, argues that the Medicare drug-benefit changes Democrats passed in 2022 without Republican support are becoming a fiscal and consumer burden. Because Democrats are campaigning on affordability, he says Republicans should challenge them now, according to Daily Caller.

The Congressional Budget Office originally projected that the Inflation Reduction Act's negotiation, rebate and benefit-redesign provisions would cut deficits by $129 billion between 2022 and 2031. It now expects them to add to deficits. Its latest outlook puts Part D spending for 2026 through 2035 roughly $700 billion above earlier estimates, with about $550 billion tied to insurers' 2026 bids, which the budget office links mainly to the redesign. Subsidies restraining premiums added $33 billion in 2024–2026.

Meanwhile, stand-alone drug plans dropped from 766 in 2022 to 360 in 2026, and average deductibles climbed from $425 in 2024 to $544 in 2026. Czwartacki wants the administration to revise negotiation pricing rules and Congress to rebalance Part D costs, though he considers a lame-duck fix a long shot.

Summarized by PolitiKool from Daily Caller’s reporting. Read the full story at Daily Caller →